Upgrade to SI Premium - Free Trial

Form 8-K QUEST DIAGNOSTICS INC For: May 20

May 21, 2026 4:49 PM
0001022079false00010220792026-05-202026-05-20

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
FORM 8-K
CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF
THE SECURITIES EXCHANGE ACT OF 1934

Date of Report (Date of Earliest Event Reported): May 20, 2026
Quest Diagnostics Incorporated
(Exact Name of Registrant as Specified in Its Charter)
Delaware
(State or other jurisdiction of incorporation)
001-1221516-1387862
(Commission File Number)(I.R.S. Employer Identification No.)
500 Plaza Drive
Secaucus, NJ07094
(Address of principal executive offices)(Zip Code)
(973)520-2700
(Registrant's telephone number, including area code)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading Symbol(s)Name of each exchange on which registered
Common Stock, $0.01 Par ValueDGXNew York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
    Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

1


Item 5.07 Submission of Matters to a Vote of Security Holders

(a)           The following is a summary of the voting results for each matter presented to the stockholders at the 2026 Annual Meeting of Stockholders which was held on May 20, 2026.

(b)           The following nominees for the office of director were elected for terms expiring at the 2027 Annual Meeting of Stockholders, by the following votes:
FOR
AGAINST
ABSTAIN
NON-VOTES
Robert B. Carter
93,821,069
205,166
173,510
9,135,906
James E. Davis
88,799,800
5,237,756
162,189
9,135,906
Luis A. Diaz, Jr., M.D.
93,909,369
110,114
180,262
9,135,906
Tracey C. Doi
93,649,938
393,268
156,539
9,135,906
Vicky B. Gregg
83,814,387
10,232,574
152,784
9,135,906
Wright L. Lassiter, III
93,802,306
223,154
174,285
9,135,906
Timothy L. Main
88,302,767
5,614,920
282,058
9,135,906
Denise M. Morrison
89,808,461
4,176,407
214,877
9,135,906
Gary M. Pfeiffer
86,302,153
7,716,970
180,622
9,135,906
Timothy M. Ring
81,917,543
11,994,424
287,778
9,135,906
Timothy C. Wentworth
93,427,490
597,095
175,160
9,135,906

The advisory resolution to approve the executive officer compensation disclosed in the Company’s 2026 Proxy Statement was approved by the following votes:

FOR
AGAINST
ABSTAIN
NON-VOTES
86,869,738
7,152,448
177,559
9,135,906

The ratification of the appointment of PricewaterhouseCoopers as the Company’s independent registered public accounting firm for 2026 was approved by the following votes:

FOR
AGAINST
ABSTAIN
97,340,034
5,809,995
185,622


The stockholder proposal regarding an independent board chairman was not approved by the following votes:

FORAGAINSTABSTAINNON-VOTES
23,999,63669,792,819407,2909,135,906



2


Signature
    
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

May 21, 2026

QUEST DIAGNOSTICS INCORPORATED
By:/s/ Sean D. Mersten
Sean D. Mersten
Vice President and Corporate Secretary



3

ATTACHMENTS / EXHIBITS

XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT

XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT

XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT

IDEA: R1.htm

IDEA: FilingSummary.xml

IDEA: MetaLinks.json

IDEA: dgx-20260520_htm.xml

Categories

SEC Filings